Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-02

Clinical Trial Update: Study of a New Medical Device in Gel Formulation Versus Calgel® for the Topical Treatment of Teething in Infants [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing a new topical gel formulation to Calgel for teething pain in infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calgel
  • New Medical Device Gel Formulation

Snippet

Sponsor: Ricerfarma S.r.l | Conditions: Pain Teeth | Phase 3 | Status: COMPLETED